Literature DB >> 2105351

The use of mupirocin in controlling methicillin-resistant Staphylococcus aureus.

H C Neu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2105351     DOI： 10.1086/646071

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  3 in total

1.  Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  H Watanabe; H Masaki; N Asoh; K Watanabe; K Oishi; S Kobayashi; A Sato; R Sugita; T Nagatake
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus.

Authors:  M Pujol; C Peña; R Pallares; J Ayats; J Ariza; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

3.  Control of methicillin-resistant Staphylococcus aureus bacteraemia in high-risk areas.

Authors:  L H Blumberg; K P Klugman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.